Healthcare -
Biotechnology - NASDAQ - US
$ 29.74
-2.14 %
$ 3.7 B
Market Cap
-14.65
P/E
APLS - OTHER LIABILITIES
Other Liabilities APLS - Apellis Pharmaceuticals, Inc.
242 M
LAST VALUE
-16.24%
2 YEAR CAGR
333.16%
5 YEAR CAGR
0.00%
10 YEAR CAGR